Skip to main content
Caplight Logo









Ordaos Bio

Ordaos Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://ordaos.bio/

Last Round

Accelerator

May 31, 2023

Total Funding Raised

$5.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ordaos Bio is a biotechnology company that utilizes a human-enabled, machine-driven drug design platform to create novel mini-proteins for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

generative AIdrug discoveryde novo protein designmini-proteinsbiotech AIin silico drug designprotein engineeringAI drug discoverybiologicstherapeutic candidatesreinforcement learningmeta-learningprecision medicinedrug developmentAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ordaos Bio Comparables

Compare Ordaos Bio with similar companies based on industry and business-model similarity.

Ordaos Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nabla Bio
85%
AI Proteins
84%
DenovAI Biotech
82%

Ordaos Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 31, 2023
SeedAug 25, 2022

Ordaos Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 36% MoM, reaching 1.4K.

  • May 31, 2023

    $300K raised from AWS Generative AI Accelerator.

Ordaos Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ordaos Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ordaos Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range24
Year Founded2019
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?